In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 30th, 2009 | 31 | Yes |
Find On: PubMed — Wikipedia — Google
CAS Number: 937174-76-0
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.86 | 4.73 | -55.01 | 5 | 10 | 1 | 142 | 426.501 | 5 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT1-2-E | RAC-alpha Serine/threonine-protein Kinase (cluster #2 Of 3), Eukaryotic | Eukaryotes | 400 | 0.29 | Binding ≤ 10μM |
AKT2-2-E | Serine/threonine-protein Kinase AKT2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 13 | 0.36 | Binding ≤ 10μM |
AKT3-2-E | Serine/threonine-protein Kinase AKT3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 9 | 0.36 | Binding ≤ 10μM |
KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1580 | 0.26 | Binding ≤ 10μM |
KS6A5-1-E | Ribosomal Protein S6 Kinase Alpha 5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 8000 | 0.23 | Binding ≤ 10μM |
ROCK1-1-E | Rho-associated Protein Kinase 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 890 | 0.27 | Binding ≤ 10μM |
Z81170-1-O | LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other | Other | 190 | 0.30 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ROCK1_HUMAN | Q13464 | Rho-associated Protein Kinase 1, Human | 890 | 0.27 | Binding ≤ 1μM |
AKT1_HUMAN | P31749 | Serine/threonine-protein Kinase AKT, Human | 2 | 0.39 | Binding ≤ 1μM |
AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 13 | 0.36 | Binding ≤ 1μM |
AKT3_HUMAN | Q9Y243 | Serine/threonine-protein Kinase AKT3, Human | 9 | 0.36 | Binding ≤ 1μM |
ROCK1_HUMAN | Q13464 | Rho-associated Protein Kinase 1, Human | 1580 | 0.26 | Binding ≤ 10μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 1580 | 0.26 | Binding ≤ 10μM |
KS6A5_HUMAN | O75582 | Ribosomal Protein S6 Kinase Alpha 5, Human | 8000 | 0.23 | Binding ≤ 10μM |
AKT1_HUMAN | P31749 | Serine/threonine-protein Kinase AKT, Human | 2 | 0.39 | Binding ≤ 10μM |
AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 13 | 0.36 | Binding ≤ 10μM |
AKT3_HUMAN | Q9Y243 | Serine/threonine-protein Kinase AKT3, Human | 9 | 0.36 | Binding ≤ 10μM |
Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 190 | 0.30 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of BAD and translocation to mitochondria | |
Activation of PKB | |
AKT phosphorylates targets in the cytosol | |
AKT phosphorylates targets in the nucleus | |
AKT-mediated inactivation of FOXO1A | |
Apoptotic cleavage of cellular proteins | |
Butyrate Response Factor 1 (BRF1) destabilizes mRNA | |
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation | |
CREB phosphorylation through the activation of Ras | |
CTLA4 inhibitory signaling | |
deactivation of the beta-catenin transactivating complex | |
Downregulation of ERBB2:ERBB3 signaling | |
eNOS activation | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
ERK/MAPK targets | |
G alpha (12/13) signalling events | |
G beta:gamma signalling through PI3Kgamma | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
GPVI-mediated activation cascade | |
Inhibition of TSC complex formation by PKB | |
Integrin alphaIIb beta3 signaling | |
KSRP destabilizes mRNA | |
NCAM signaling for neurite out-growth | |
Negative regulation of the PI3K/AKT network | |
PDE3B signalling | |
PIP3 activates AKT signaling | |
Recycling pathway of L1 | |
RSK activation | |
Sema4D induced cell migration and growth-cone collapse | |
Senescence-Associated Secretory Phenotype (SASP) | |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |
Translocation of GLUT4 to the plasma membrane | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated vascular permeability |
No pre-computed analogs available. Try a structural similarity search.